| Net Cash Provided by (Used in) Operating Activities |
$989,142 |
USD |
-166% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,100,000 |
USD |
450% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$37,797 |
USD |
-119% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
154,898,024 |
shares |
0.38% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$73,061 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$549,202 |
USD |
86% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$14,935 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$549,202 |
USD |
86% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Additional Paid in Capital |
$3,697,698 |
USD |
45% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$549,202 |
USD |
86% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |